Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma
Y N Vashisht Gopal, Seth Gammon, Rishika Prasad, et al.
Leukemia
|
August 31, 2016
Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target
Gheath Alatrash, Haven R Garber, Mao Zhang, et al.
Journal of the National Cancer Institute
|
December 22, 2017
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy
Jodi A McKenzie, Rina M Mbofung, Shruti Malu, et al.
Nature Communications
|
February 22, 2020
Immuno-genomic landscape of osteosarcoma
Chia-Chin Wu, Hannah C Beird, J Andrew Livingston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Phase I Study of P-cadherin-targeted Radioimmunotherapy with <sup>90</sup>Y-FF-21101 Monoclonal Antibody in Solid Tumors
Vivek Subbiah, William Erwin, Osama Mawlawi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Lu Huang, Shruti Malu, Jodi A McKenzie, et al.
Nature Communications
|
September 8, 2017
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes
Rina M Mbofung, Jodi A McKenzie, Shruti Malu, et al.
PNAS Nexus
|
August 25, 2022
Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I molecules
Kyle R Jackson, Dinler A Antunes, Amjad H Talukder, et al.
Cancer Immunology, Immunotherapy : CII
|
October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
Simone Punt, Shruti Malu, Jodi A McKenzie, et al.
Nature Communications
|
October 22, 2020
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers
Sherille D Bradley, Amjad H Talukder, Ivy Lai, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma
Y N Vashisht Gopal, Seth Gammon, Rishika Prasad, et al.
Leukemia
|
August 31, 2016
Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target
Gheath Alatrash, Haven R Garber, Mao Zhang, et al.
Journal of the National Cancer Institute
|
December 22, 2017
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy
Jodi A McKenzie, Rina M Mbofung, Shruti Malu, et al.
Nature Communications
|
February 22, 2020
Immuno-genomic landscape of osteosarcoma
Chia-Chin Wu, Hannah C Beird, J Andrew Livingston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Phase I Study of P-cadherin-targeted Radioimmunotherapy with <sup>90</sup>Y-FF-21101 Monoclonal Antibody in Solid Tumors
Vivek Subbiah, William Erwin, Osama Mawlawi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Lu Huang, Shruti Malu, Jodi A McKenzie, et al.
Nature Communications
|
September 8, 2017
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes
Rina M Mbofung, Jodi A McKenzie, Shruti Malu, et al.
PNAS Nexus
|
August 25, 2022
Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I molecules
Kyle R Jackson, Dinler A Antunes, Amjad H Talukder, et al.
Cancer Immunology, Immunotherapy : CII
|
October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
Simone Punt, Shruti Malu, Jodi A McKenzie, et al.
Nature Communications
|
October 22, 2020
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers
Sherille D Bradley, Amjad H Talukder, Ivy Lai, et al.
Page
of 17